Alavert and Guaifenesin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alavert (loratadine) and Guaifenesin (guaifenesin). Common drug interactions include cartilage injury among females and haemoptysis among males.

The phase IV clinical study analyzes what interactions people have when they take Alavert and Guaifenesin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Alavert?

Alavert has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 2,062 Alavert users. Check the latest studies of Alavert.

What is Guaifenesin?

Guaifenesin has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 12,106 Guaifenesin users. Check the latest studies of Guaifenesin.

On Jul, 06, 2026

13 people who take Alavert and Guaifenesin together, and have interactions are studied.

Alavert and Guaifenesin drug interactions.

What are the common drug interactions of Alavert and Guaifenesin, by gender? *:

female:

Cartilage injury
Chronic kidney disease
Connective tissue disorder (any disease that has the connective tissues of the body)
Contusion (a type of hematoma of tissue in which capillaries)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Dizziness
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Erythema (redness of the skin)
Fall

male:

Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Chronic kidney disease

What are the common drug interactions of Alavert and Guaifenesin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Nausea (feeling of having an urge to vomit)
Asthma
Bone deformity
Cardiovascular disorder (heart diseases)
Chronic kidney disease
Dizziness
Drug ineffective
Fall
Fatigue (feeling of tiredness)
Femur fracture

60+:

Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Abscess fungal (pus produced by a fungal infection)
Gingival pain (gum pain)
Hypoaesthesia (reduced sense of touch or sensation)
Injection site bruising
Injection site discolouration
Injection site erythema (redness at injection site)
Injection site mass
Injection site pain
Injection site swelling

What are the existing conditions these people have? *

Asthma: 6 people, 46.15%
High Blood Pressure: 3 people, 23.08%
Nausea (feeling of having an urge to vomit): 3 people, 23.08%
Hypersensitivity: 3 people, 23.08%
Diabetes: 3 people, 23.08%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 15.38%
Infection: 2 people, 15.38%
Gout (uric acid crystals building up in the body): 2 people, 15.38%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 15.38%
Hyperkalemia (damage to or disease of the kidney): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Alavert and Guaifenesin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously